Try our beta test site
1 study found for:    lymphoma OR CLL | IPH2201
Show Display Options
Rank Status Study
1 Recruiting Combination Study of IPH2201 With Ibrutinib in Patients With Relapsed, Refractory or Previously Untreated Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: monalizumab

Study has passed its completion date and status has not been verified in more than two years.